These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1966580)

  • 1. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
    Nedrud JG; Sigmund N
    Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus.
    Liang XP; Lamm ME; Nedrud JG
    J Immunol; 1988 Sep; 141(5):1495-501. PubMed ID: 2842395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice.
    Liang XP; Lamm ME; Nedrud JG
    Reg Immunol; 1989; 2(4):244-8. PubMed ID: 2561961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined oral/nasal immunization protects mice from Sendai virus infection.
    Nedrud JG; Liang XP; Hague N; Lamm ME
    J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.
    Pierre P; Denis O; Bazin H; Mbongolo Mbella E; Vaerman JP
    Eur J Immunol; 1992 Dec; 22(12):3179-82. PubMed ID: 1446708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
    Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
    Bianchi AT; Zwart RJ; Van der Heijden PJ
    Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice.
    Low PP; Rutherfurd KJ; Gill HS; Cross ML
    Int Immunopharmacol; 2003 Mar; 3(3):393-401. PubMed ID: 12639817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodulation of rat serum and mucosal antibody responses to Entamoeba histolytica trophozoites by beta-1,3-glucan and cholera toxin.
    Navarro-García F; Pedroso M; López-Revilla R
    Clin Immunol; 2000 Nov; 97(2):182-8. PubMed ID: 11027459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin.
    Snider DP; Marshall JS; Perdue MH; Liang H
    J Immunol; 1994 Jul; 153(2):647-57. PubMed ID: 8021502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
    Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
    Israf DA; Lajis NH; Somchit MN; Sulaiman MR
    Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.
    Marinaro M; Staats HF; Hiroi T; Jackson RJ; Coste M; Boyaka PN; Okahashi N; Yamamoto M; Kiyono H; Bluethmann H; Fujihashi K; McGhee JR
    J Immunol; 1995 Nov; 155(10):4621-9. PubMed ID: 7594461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
    Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
    J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model.
    Rolland-Turner M; Farre G; Muller D; Rouet N; Boue F
    Vaccine; 2004 Oct; 22(31-32):4163-72. PubMed ID: 15474706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.